跳至主要内容
临床试验/EUCTR2014-002107-16-AT
EUCTR2014-002107-16-AT进行中(未招募)不适用

Double blind randomized study to evaluate the efficiency of intravenous ferric carboxymaltose in preventing anemia after cardiopulmonary bypass in children with congenital heart disease - Anemiastudy

General Hospital Linz0 个研究点开始时间: 2014年7月21日最近更新:
相关药物

试验速览

阶段
不适用
状态
进行中(未招募)
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • age 0-18 years
  • open heart surgery with cardiopulmonary bypass
  • informed parental consent
  • 0-2 months hemoglobin under 16g/dl
  • 3months - 6 years hemoglobin under 12 g/dl
  • 6 - 18 years under hemoglobin under 13,5g/dl
  • Are the trial subjects under 18? yes
  • Number of subjects for this age range: 100
  • F.1.2 Adults (18-64 years) no
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) no
  • F.1.3.1 Number of subjects for this age range

排除标准

  • re do operation
  • postoperative extracorporal membrane oxgenation
  • massive transfusion
  • preceeding intravenous iron therapy
  • 0-2 months hemoglobin over 16g/dl
  • 3 months to 6 years over 12g/dl
  • 6 to 18 years over 13,5g/dl
  • missing informed consent

研究者

发起方
General Hospital Linz

相似试验

已完成
不适用
Randomized Double Blind Study to Evaluate the Efficacy of Droperidol Added to Patient-Controlled Epidural Analgesia with fentanyl for Prevention of Post-Operative Nausea and Vomiting in Subjects Undergoing Gynecologic SurgeryCondition is enough to require surgery under combined general-epidural anesthesia, for example myoma of the uterus, ovarian cyst, denomyosis of the uterus, uterine corpus cancer, uterine cervical cancer, and cancer of ovary et al.
JPRN-UMIN000006405niversity of Yamanashi Hospital150
进行中(未招募)
不适用
Randomized double blind trial to evaluate the efficacy and safety of dronedarone (400 mg BID) versus amiodarone (600 mg daily for 28 days then 200 mg daily thereafter) for at least 6 months for the maintenance of sinus rhythm in patients with atrial fibrillation (AF) - DIONYSOSMedDRA version: 9.1Level: LLTClassification code 10003658Term: Atrial fibrillationAtrial Fibrillation
EUCTR2006-005804-15-DEsanofi-aventis recherche & développement472
进行中(未招募)
不适用
Randomized double blind trial to evaluate the efficacy and safety of dronedarone (400 mg BID) versus amiodarone (600 mg daily for 28 days then 200 mg daily thereafter) for at least 6 months for the maintenance of sinus rhythm in patients with atrial fibrillation (AF) - DIONYSOSMedDRA version: 9.1Level: LLTClassification code 10003658Term: Atrial fibrillationAtrial Fibrillation
EUCTR2006-005804-15-CZsanofi-aventis recherche & développement472
进行中(未招募)
1 期
Randomized double blind trial to evaluate the efficacy and safety of dronedarone (400 mg BID) versus amiodarone (600 mg daily for 28 days then 200 mg daily thereafter) for at least 6 months for the maintenance of sinus rhythm in patients with atrial fibrillation (AF) - DIONYSOSMedDRA version: 9.1Level: LLTClassification code 10003658Term: Atrial fibrillationAtrial Fibrillation
EUCTR2006-005804-15-PLsanofi-aventis recherche & développement472
进行中(未招募)
不适用
Randomized double blind trial to evaluate the efficacy and safety of dronedarone (400 mg BID) versus amiodarone (600 mg daily for 28 days then 200 mg daily thereafter) for at least 6 months for the maintenance of sinus rhythm in patients with atrial fibrillation (AF) - DIONYSOSAtrial Fibrillation
EUCTR2006-005804-15-FIsanofi-aventis recherche & développement472